Wide Ranks

MAIA

MAIA Biotechnology, Inc.

2.18

Top Statistics
Market Cap 55 M Forward PE -1.61 Revenue Growth 0.00 %
Current Ratio 3.42 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 11 M Total Cash Per Share 0.4840 Total Debt
Total Debt To Equity Current Ratio 3.42 Book Value Per Share 0.0280
All Measures
Short Ratio 1099.00 % Message Board Id finmb_631239285 Shares Short Prior Month 693528
Return On Equity -5.60 City Chicago Uuid 0f42043f-a188-3808-9a57-e38f76c4260b
Previous Close 2.22 First Trade Date Epoch Utc 1 B Book Value 0.0280
Beta 0.3400 Volume 98261 Price To Book 77.86
Fifty Two Week Low 0.8200 Total Cash Per Share 0.4840 Shares Short Previous Month Date 1 B
Target Median Price 12.62 Max Age 86400 Recommendation Mean 1.00
Sand P52 Week Change 0.3133 Target Mean Price 12.62 Net Income To Common -28079136
Ask 2.18 Short Percent Of Float 0.0330 Implied Shares Outstanding 25 M
Last Fiscal Year End 1 B Trailing Peg Ratio None Average Daily Volume10 Day 135240
Average Volume10days 135240 Total Cash 11 M Next Fiscal Year End 1 B
Held Percent Insiders 0.1749 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 2.22 Target Low Price 11.25
Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.60 Open 2.22
Free Cashflow -8808264 State IL Dividend Yield 0.00 %
Return On Assets -1.07 Time Zone Short Name EST Trailing Eps -1.34
Day Low 2.08 Address1 444 West Lake Street Shares Outstanding 25 M
Price Hint 4 Target High Price 14.00 Website https://maiabiotech.com
52 Week Change 1.18 Average Volume 134187 Forward Eps -1.58
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 334.90 %
Is_sp_500 False Regular Market Day High 2.22 Profit Margins 0.00 %
Fifty Two Week High 5.99 Day High 2.22 Shares Short 662415
Regular Market Open 2.22 Industry Key biotechnology Bid 2.08
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0276
Operating Cashflow -15421306 Currency USD Time Zone Full Name America/New_York
Market Cap 55 M Is_nasdaq_100 False Zip 60606
Quote Type EQUITY Industry Biotechnology Long Name MAIA Biotechnology, Inc.
Regular Market Day Low 2.08 Held Percent Institutions 0.0751 Current Price 2.18
Address2 Suite 1700 Financial Currency USD Current Ratio 3.42
Industry Disp Biotechnology Number Of Analyst Opinions 2 Country United States
Float Shares 19 M Two Hundred Day Average 2.78 Enterprise Value 51 M
Forward PE -1.61 Regular Market Volume 98261 Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.

Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells.

The company was incorporated in 2018 and is headquartered in Chicago, Illinois.